Cosmo First Purchases Mumbai's Prolife Specialty Vet Clinic To Enhance Zigly Division

Market snapshot: Cosmo First's pet care subsidiary, Zigly, has successfully acquired Mumbai-based Prolife Specialty Vet Clinic LLP through a slump sale. This strategic clinical addition allows Zigly to aggressively expand its veterinary care footprint in Western India. The move integrates an established local brand with robust unit economics into Cosmo First's fast-growing B2C consumer ecosystem.

Data Snapshot

• Prolife Specialty Vet Clinic LLP generates an Annual Recurring Revenue of ₹4.36 crore from its single established Mumbai location.
• The clinic's historical turnover surged to ₹1.95 crore in FY26, compared to a steady revenue of ₹83 lakh in both FY24 and FY25.
• Cosmo First's consumer-focused petcare brand Zigly posted a robust 70% YoY revenue growth during the first quarter of FY27.

What's Changed

• The acquired clinic's turnover increased by ≈135% YoY in FY26 (derived: ₹1.95 crore vs ₹83 lakh in FY25), pointing to accelerating business demand.
• The acquisition further consolidates Zigly's clinical presence in Western India, supplementing its earlier clinical transaction of Small Animal Clinic in Khar West.

Key Takeaways

• Zigly secures an established clinic with two decades of operations and a reliable database of approximately 20,000 treated pets.
• The bolt-on model allows Zigly to ramp up service revenues and specialized care capabilities without incurring the heavy gestation lags of greenfield developments.
• Converting the clinic's operational framework to 24x7 service hours is expected to maximize revenue per square foot and improve segment EBITDA margins.

SAHI Perspective

Cosmo First's strategy of executing targeted, cash-generating acquisitions for Zigly stands out as highly capital-efficient. By integrating profitable regional clinics with stable client databases rather than relying solely on high-burn retail rollouts, the company is systematically moving the B2C segment toward operational break-even while insulating itself from commodity packaging cycles.

Market Implications

Although packaging and industrial film segments remain Cosmo First's core profit engines, the persistent scaling of B2C verticals like Zigly (up 70% YoY in Q1 FY27) serves as a strategic valuation hedge. Strong expansion in specialized services improves aggregate margins and helps pave a clear roadmap toward group-level ROCE improvement as capital expenditures on major B2B projects conclude.

Trading Signals

Market Bias: Bullish

Cosmo First's latest acquisition adds a clinical asset with a ₹4.36 crore ARR to its high-growth B2C brand Zigly (which registered 70% YoY growth in Q1 FY27). The transaction employs high unit-economic bolt-on scaling, advancing Zigly's projected path toward operational break-even.

Overweight: Petcare Services, Specialized Healthcare Services, Consumer Discretionary

Underweight: Commodity Packaging Films (due to near-term pressure on BOPP margins)

Trigger Factors:

• EBITDA break-even progression for Zigly's store and clinic network (estimated within 12-15 months).
• Margin recovery trends in the domestic BOPP and BOPET packaging divisions.
• Successful integration and transition of the clinical facility to 24x7 operational hours.

Time Horizon: Medium-term (3-12 months)

Industry Context

The Indian pet care segment is growing rapidly at an estimated annual rate of over 25%, driven by humanization trends and higher disposable incomes. Organized consolidation is ramping up as major retail brands acquire individual, fragmented vet practices to capture a bigger share of high-margin clinical and surgical services.

Key Risks to Watch

• Retaining key medical and administrative personnel post-acquisition.
• Short-term increase in overhead costs as operational models transition to 24x7 service hours.
• Sustained domestic packaging margin pressures limiting the capital allocation potential for consumer B2C expansions.

Recent Developments

Cosmo First completed its major strategic capital expenditure cycle of ₹1,200+ crore over the last three years. In Q1 FY27, the company reported that all B2B segments are profitable, and net debt remained stable at ₹1,166 crore as of June 30, 2026, with a clear corporate goal to lower its Net Debt/EBITDA ratio to below 2.0x within 12 to 18 months.

Closing Insight

The acquisition of Prolife Specialty Vet Clinic exemplifies Cosmo First's disciplined corporate playbook for its consumer division. By prioritising unit-economic strength and clinical specialization over simple store-count expansion, Cosmo First is successfully positioning Zigly as a sustainable margin driver of the future.

High Performance Trading with SAHI.